Dear AuntMinnie Member,
U.S. researchers are reporting on a new PET technique that they say can help differentiate malignant from benign breast tissue, and can also detect local and distant metastases from primary breast cancer.
The technique, called dual-time-point PET, involves scanning patients at two separate intervals in order to quantify radiotracer uptake, according to an article we're featuring this week in our Molecular Imaging Digital Community by staff writer Jonathan S. Batchelor.
The researchers found that while malignant tissue showed positive changes in radiotracer uptake between the two imaging time points, normal breast tissue showed either no change or a negative change. Different subtypes of breast cancer also demonstrated different time-point characteristics, they said. Learn more about their findings by clicking here.
In another featured article, staff writer Shalmali Pal investigates recent research using various radiopharmaceuticals for imaging endocrine cancers. The studies range from a Polish group that evaluated therapy with a radiolabeled somatostatin analogue to French researchers who compared PET to somatostatin reception scintigraphy. Learn about these studies by clicking here.
Get these stories and more by visiting our Molecular Imaging Digital Community, at molecular.auntminnie.com.
